Active Ingredients

Molecule
Status
ATC Group
No results matching you criteria!

AGOMELATINE / AGOMELATINE COCRYSTAL

Status:
-
ATC Group:
-

APIXABAN

Status:
-
ATC Group:
-

ARTICAINE HCL

Status:
ASMF available
ATC Group:
-

ELVITEGRAVIR

Status:
-
ATC Group:
-

GLIBENCLAMIDE

Status:
ASMF available
ATC Group:
-

IVACAFTOR

Status:
-
ATC Group:
-

LERCANIDIPINE

Status:
-
ATC Group:
-

PENTOXIFYLLINE

Status:
ASMF available
ATC Group:
-

PERINDOPRIL ARGININE

Status:
-
ATC Group:
-

PIRETANIDE

Status:
-
ATC Group:
-

RAMIPRIL

Status:
-
ATC Group:
-

RILMENIDINE DIHYDROGENPHOSPHATE

Status:
-
ATC Group:
-

RIVAROXABAN

Status:
-
ATC Group:
-

S-AMLODIPINE

Status:
-
ATC Group:
-

S-IBUPROFEN

Status:
-
ATC Group:
-

SACUBITRIL SODIUM

Status:
-
ATC Group:
-

TAMSULOSIN HYDROCHLORIDE

Status:
-
ATC Group:
-

TENOFOVIR ALAFENAMIDE

Status:
-
ATC Group:
-

TEZACAFTOR

Status:
-
ATC Group:
-

VALSARTAN SODIUM

Status:
-
ATC Group:
-

VORTIOXETINE HYDROBROMIDE

Status:
-
ATC Group:
-

DISCLAIMER:

Any disposal with the product, including but not limited to the development, sale and offer for sale of products and related processes identified within this catalogue is performed by Zentiva only in those territories where it is permissible by applicable patent law; in particular, but not limited to Art. 10 EC Directive 2001/83. This catalogue shall not constitute an offer for sale of products and processes for the territories where an offer for sale or sale is not permissible by law. Zentiva expressly disclaims any liability for damages resulting from or arising out of the unauthorised use of such products and related processes.